Accessibility Menu
Clever Culture Systems logo

Clever Culture Systems(ASX) CC5

Market CapA$32.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2006)-89%
5 Year-78%
1 Year-56%
1 Month-32%
A$0.02
+7.14%
+0.00Today
Clever Culture Systems last closing stock price
MetricPriceDate
Last closeAUD 0.022026-08-14
Clever Culture Systems stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.022026-08-07
1 month-31.82%AUD 0.022026-07-15
3 month-34.78%AUD 0.022026-05-15
Year to date-48.28%AUD 0.032025-12-31
1 year-55.88%AUD 0.032025-08-14
3 year-17.58%AUD 0.022023-08-15
5 year-77.91%AUD 0.072021-08-13
Since inception-89.01%AUD 0.142006-07-31

Clever Culture Systems Financials at a Glance

Market Cap

A$32.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-A$0.00

P/E Ratio

-37.50

Dividend

A$0.00

Beta (Volatility)

-0.02 (Low)

Price

A$0.02

Volume

0

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.01 - A$0.04

Estimated Earnings Date

Sep 2, 2026

CC5 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Clever Culture Systems

Clever Culture Systems Limited is an innovative company based in Adelaide, Australia, specializing in advanced technological solutions for the medical industry. Established in 2004, the company focuses on the development and market launch of products that enhance microbiology laboratory operations globally.

Products and Services
  • Automated Plate Assessment System (APAS) for microbiology culture analysis
  • Digital Microbiology solutions for enhanced laboratory efficiency
  • Specialized APAS modules utilizing artificial intelligence for culture plate reading
Growth Outlook
  • Expansion into international markets, including the US and Europe
  • Continued development of APAS technology for diverse medical applications
  • Increased demand for automation in microbiology laboratories
Financial Highlights
  • Recent quarterly revenue of AUD 2.54 million, showing steady performance
  • Trailing twelve months (TTM) cash flow coverage ratio of 0.80, indicating strong liquidity
  • Current ratio of 2.81, reflecting solid short-term financial health
Clever Culture Systems Limited operates in the Medical - Diagnostics & Research sector, providing essential tools for microbiology laboratories. The company's flagship product, the Automated Plate Assessment System (APAS), is designed to streamline the analysis of microbiology culture plates, significantly improving efficiency and accuracy in laboratory settings. The growth outlook for Clever Culture Systems is promising, with plans to expand into new international markets and enhance its product offerings. The increasing demand for automation in laboratories presents a significant opportunity for the company to capture a larger market share. Financially, the company has demonstrated resilience, with a recent quarterly revenue of AUD 2.54 million. The TTM cash flow coverage ratio of 0.80 indicates a strong ability to meet short-term obligations, while a current ratio of 2.81 suggests robust liquidity. These financial metrics highlight the company's potential for sustainable growth and operational stability in the evolving medical technology landscape.
AI Generated • Aug 15, 2026

Industry

Healthcare Equipment and Supplies

Employees

26

CEO

Brenton John Barnes

Headquarters

Adelaide, SA 5000, AU

CC5 Financials

Key Financial Metrics (TTM)

Gross Margin

-3.48%

Operating Margin

-48.70%

Net Income Margin

-14.38%

Return on Equity

-10.90%

Return on Capital

-14.94%

Return on Assets

-5.92%

Earnings Yield

-2.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$32.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.18B

Volume

0

Avg. Volume

824.78K

Financials (TTM)

Gross Profit

-A$180.00K

Operating Income

-A$2.52M

EBITDA

-A$1.92M

Operating Cash Flow

A$1.05M

Capital Expenditure

-A$22.00K

Free Cash Flow

A$1.03M

Cash & ST Invst.

A$3.10M

Total Debt

A$1.31M

Clever Culture Systems Performance Analysis

Clever Culture Systems annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 2,128,000N/A
20232023-06-30AUD 2,132,0000.2%
20242024-06-30AUD 1,256,000-41.1%
20252025-06-30AUD 5,461,000334.8%
Clever Culture Systems sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q42025-06-30N/A
Q22025-12-31-3.9%
Clever Culture Systems annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.02N/A
20232023-06-30AUD -0.05214.5%
20242024-06-30AUD -0.00-91.6%
20252025-06-30AUD 0.00N/A
Clever Culture Systems sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q42025-06-30N/A
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

A$2.54M

N/A

Gross Profit

-A$335.00K

N/A

Gross Margin

-13.21%

N/A

Market Cap

A$32.69MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.26M

N/A

Employees

26

N/A

Net Income

-A$1.32M

N/A

EBITDA

-A$1.31M

N/A

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Total Cash

A$3.10M

N/A

Total Debt

A$1.31M

N/A

Accounts Receivable

A$1.72M

N/A

Inventory

A$2.16M

N/A

Long Term Debt

A$1.09M

N/A

Short Term Debt

A$223.00K

N/A

Return on Assets

-5.92%

N/A

Return on Invested Capital

-24.98%

N/A

Free Cash Flow

A$190.00K

N/A

Operating Cash Flow

A$193.00K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CHM.AXChimeric Therapeutics Limited
A$0.04-12.50%
ATX.AXAmplia Therapeutics Limited
A$0.15+0.00%
PTX.AXPrescient Therapeutics Limited
A$0.09+3.61%
DXB.AXDimerix Limited
A$0.30+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About CC5

What is the current price of Clever Culture Systems?

Clever Culture Systems is trading at A$0.02 per share.

What is the 52-week range for Clever Culture Systems?

Over the past 52 weeks, Clever Culture Systems has traded between A$0.01 and A$0.04.

How much debt does Clever Culture Systems have?

As of the most recent reporting period, Clever Culture Systems reported total debt of A$2.04M.

How much cash does Clever Culture Systems have on hand?

Clever Culture Systems reported A$1.27M in cash and cash equivalents in its most recent financial results.

What is Clever Culture Systems’s dividend yield?

Clever Culture Systems does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.